All updates
All updates
today 39监管与产业动态评分2424 监管与产业动态评分2323 Teva, Samsung Bioepis deepen bonds in pact for up to 6 new biosimilars - Fierce Pharma
监管与产业动态评分2020 ‘We’ve been taking our time’: Buzzy AI biotech Xaira reveals antibody platform, first taste of pipeline - Fierce Biotech
监管与产业动态评分2727 Pharma partnering in China gets earlier and broader
监管与产业动态精选评分3838 Circle’s $92.5M round puts cyclin D1 program ahead of clinical lead
监管与产业动态评分6767 Novartis turns to mRNA-encoded engagers for B cell depletion
监管与产业动态评分2121 'The best is yet to come': Bayer doubles down on US with plans for $2.2B Ohio manufacturing site - Fierce Pharma
监管与产业动态评分44 Naven Health - Fierce Pharma
中文产业新闻精选Chinese source评分7070 诺华与艾博生物达成ABO2203全球许可协议，首付5.75亿美元、里程碑72亿美元
中文产业新闻精选Chinese source评分6666 默沙东引进思璞锐KRAS G12D(ON)抑制剂SPR2015，首付4亿美元总价21.3亿美元并申报IND
中文产业新闻Chinese source评分1515 约78亿美元，诺华与艾博生物就ABO2203等RNA疗法达成全球独家许可
中文产业新闻Chinese source评分2929 Varda完成2.51亿美元D轮融资，要把空间站实验变成一条制药工艺
中文产业新闻Chinese source评分6666 艾博生物与诺华达成约78亿美元mRNA-TCE授权协议
中文产业新闻精选Chinese source评分3434 Varda太空药物CRO，会重塑医药竞争格局吗？
中文产业新闻Chinese source评分1717 BioNTech 疫苗产能过剩卖不动，再关停三家德国 mRNA 生产基地
社区讨论（Reddit）评分4444 Foghorn lays off 40% of employees as Lilly cancer collab collapses over poor data
社区讨论（Reddit）评分3737 Florida Attorney General sues Pfizer and CEO over COVID-19 vaccine claims
中文产业新闻精选Chinese source评分5151 国产口服减肥药达成海外授权，3亿美元首付、最高26亿美元总金额
中文产业新闻精选Chinese source评分6161 Zealand Pharma amylin 类似物 petrelintide II 期 42 周减重 10.7%，三项 III 期注册研究同步启动
监管与产业动态评分5252 Sanofi pays Dupixent partner Regeneron $1B upfront for 4 early-stage assets to ignite R&D - Fierce Biotech
监管与产业动态评分99 Asahi Kasei wraps years of global dealmaking into a single brand - Fierce Pharma
监管与产业动态评分77 Real Chemistry launches AI-powered MaestroHCP to conduct omnichannel campaigns - Fierce Pharma
监管与产业动态评分4242 Foghorn lays off 40% of employees as Lilly cancer collab collapses over poor data - Fierce Biotech
监管与产业动态评分88 Johnson & Johnson survey finds women not connecting menopause to eye health changes - Fierce Pharma
监管与产业动态评分2424 Roche launches simultaneous screening test for SMA, SCID and SCD - Fierce Biotech
监管与产业动态评分66 It's 'About Damn Time' to highlight the post-treatment breast cancer journey, Genentech says in new campaign - Fierce Pharma
中文产业新闻精选Chinese source评分5555 赛诺菲以10亿美元首付向再生元引进4款早期2型炎症长效抗体
中文产业新闻精选Chinese source评分6868 艾博生物与诺华达成 mRNA-TCE 管线授权，首付款 5.75 亿美元、总规模最高 77.75 亿美元
中文产业新闻精选Chinese source评分5858 思璞锐与默沙东就口服KRAS G12D(ON)抑制剂SPR2015达成全球独家授权，首付款4亿美元
社区讨论（Reddit）评分1818 What's the worst layoff you've ever experienced?
中文产业新闻Chinese source评分3838 当恒瑞越来越像Biotech
BioPharma Dive评分3333 Lilly, Foghorn part ways; Wave’s FDA-approved plans
BioSpace评分3434 Varda raises $251M to leverage gravity in space for drug production
STAT News评分2929 STAT+: Lilly bypasses Australian pharmacies with DTC model
BioPharma Dive精选评分6565 Novartis wagers almost $8B on a Chinese biotech’s RNA drugs
监管与产业动态评分4444 Trio of biotechs draw nine-figure fundings: Public Equity Report
STAT News评分2727 STAT+: Pharmalittle: We’re reading about the 340B drug pilot program, an obesity drug disappointment, and more
STAT News评分88 STAT+: Up and down the ladder: The latest comings and goings
中文产业新闻Chinese source评分4242 艾博生物与诺华达成77.75亿美元mRNA BD交易：ABO2203全球独家许可授予诺华
BioSpace评分6464 Novartis bets up to $7.8B for an mRNA-encoded T cell engager from China’s Abogen